{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T04:32:16Z","timestamp":1781757136516,"version":"3.54.5"},"reference-count":35,"publisher":"Elsevier BV","issue":"39","license":[{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100015631","name":"Merck Canada Inc","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100015631","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2021,9]]},"DOI":"10.1016\/j.vaccine.2021.08.061","type":"journal-article","created":{"date-parts":[[2021,8,25]],"date-time":"2021-08-25T07:31:15Z","timestamp":1629876675000},"page":"5474-5483","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Whole genome characterization of Streptococcus pneumoniae from respiratory and blood cultures collected from Canadian hospitals before and after PCV-13 implementation in Canada: Focus on serotypes 22F and 33F from CANWARD 2007\u20132018"],"prefix":"10.1016","volume":"39","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1788-1794","authenticated-orcid":false,"given":"Alyssa R.","family":"Golden","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5646-6454","authenticated-orcid":false,"given":"Heather J.","family":"Adam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melanie","family":"Baxter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irene","family":"Martin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Walter","family":"Demczuk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael R.","family":"Mulvey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James A.","family":"Karlowsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George G.","family":"Zhanel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2021.08.061_b0005","unstructured":"National Advisory Committee on Immunization (NACI). Update on the use of pneumococcal vaccines in adults 65 years of age and older - A public health perspective; 2018."},{"issue":"9","key":"10.1016\/j.vaccine.2021.08.061_b0010","doi-asserted-by":"crossref","first-page":"2130","DOI":"10.1016\/j.vaccine.2009.12.026","article-title":"The effect of routine vaccination on invasive pneumococcal infections in Canadian children, Immunization Monitoring Program, Active 2000\u20132007","volume":"28","author":"Bettinger","year":"2010","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.vaccine.2021.08.061_b0015","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1086\/648593","article-title":"Sustained reductions in invasive pneumococcal disease in the era of conjugate vaccine","volume":"201","author":"Pilishvili","year":"2010","journal-title":"J Infect Dis"},{"issue":"12","key":"10.1016\/j.vaccine.2021.08.061_b0020","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1139\/cjm-2013-0614","article-title":"Serotype distribution of invasive Streptococcus pneumoniae in Canada after the introduction of the 13-valent pneumococcal conjugate vaccine, 2010\u20132012","volume":"59","author":"Demczuk","year":"2013","journal-title":"Can J Microbiol"},{"issue":"Suppl 7","key":"10.1016\/j.vaccine.2021.08.061_b0025","doi-asserted-by":"crossref","first-page":"vii12","DOI":"10.1093\/jac\/dky158","article-title":"Analysis of multidrug resistance in the predominant Streptococcus pneumoniae serotypes in Canada: The SAVE study, 2011\u201315","volume":"73","author":"Adam","year":"2018","journal-title":"J Antimicrob Chemother"},{"issue":"45","key":"10.1016\/j.vaccine.2021.08.061_b0030","doi-asserted-by":"crossref","first-page":"6883","DOI":"10.1016\/j.vaccine.2018.02.113","article-title":"Safety and immunogenicity of 15-valent pneumococcal conjugate vaccine (PCV15) in healthy infants","volume":"36","author":"Greenberg","year":"2018","journal-title":"Vaccine"},{"issue":"45","key":"10.1016\/j.vaccine.2021.08.061_b0035","doi-asserted-by":"crossref","first-page":"6875","DOI":"10.1016\/j.vaccine.2018.03.012","article-title":"Safety and immunogenicity of 15-valent pneumococcal conjugate vaccine in pneumococcal vaccine-na\u00efve adults \u226550 years of age","volume":"36","author":"Ermlich","year":"2018","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2021.08.061_b0040","doi-asserted-by":"crossref","unstructured":"Hurley D, Griffin C, Young M, Scott DA, Pride MW, Scully IL, et al. Safety, tolerability, and immunogenicity of a 20-valent pneumococcal conjugate vaccine (PCV20) in adults 60 to 64 years of age. Clin Infect Dis 2020:ciaa1045.","DOI":"10.1093\/cid\/ciaa1045"},{"issue":"Suppl 7","key":"10.1016\/j.vaccine.2021.08.061_b0045","doi-asserted-by":"crossref","first-page":"vii20","DOI":"10.1093\/jac\/dky157","article-title":"Molecular characterization of predominant Streptococcus pneumoniae serotypes causing invasive infections in Canada: The SAVE study, 2011-15","volume":"73","author":"Golden","year":"2018","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.vaccine.2021.08.061_b0050","doi-asserted-by":"crossref","unstructured":"Zhanel GG, Adam HJ, Baxter MR, Fuller J, Nichol KA, Denisuik AJ, et al. 42936 pathogens from Canadian hospitals: 10 years of results (2007\u201316) from the CANWARD surveillance study. J Antimicrob Chemother 2019;74 (Suppl 4):iv5\u201321.","DOI":"10.1093\/jac\/dkz283"},{"key":"10.1016\/j.vaccine.2021.08.061_b0055","unstructured":"Clinical and Laboratory Standards Institute (CLSI). Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria That Grow Aerobically. M07, 11th Edition. Wayne, PA, USA: 2018."},{"key":"10.1016\/j.vaccine.2021.08.061_b0060","unstructured":"Clinical and Laboratory Standards Institute (CLSI). Performance Standards for Antimicrobial Susceptibility Testing. M100, 30th Edition. Wayne, PA, USA: 2020."},{"key":"10.1016\/j.vaccine.2021.08.061_b0065","first-page":"699","article-title":"The Quellung reaction, a neglected microbiologic technique","volume":"43","author":"Austrian","year":"1976","journal-title":"Mt Sinai J Med"},{"issue":"5","key":"10.1016\/j.vaccine.2021.08.061_b0070","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1089\/cmb.2012.0021","article-title":"SPAdes: a new genome assembly algorithm and its applications to single-cell sequencing","volume":"19","author":"Bankevich","year":"2012","journal-title":"J Comput Biol"},{"issue":"3","key":"10.1016\/j.vaccine.2021.08.061_b0075","doi-asserted-by":"crossref","first-page":"R46","DOI":"10.1186\/gb-2014-15-3-r46","article-title":"Kraken: Ultrafast metagenomic sequence classification using exact alignments","volume":"15","author":"Wood","year":"2014","journal-title":"Genome Biol"},{"key":"10.1016\/j.vaccine.2021.08.061_b0080","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/j.ebiom.2019.04.021","article-title":"International genomic definition of pneumococcal lineages, to contextualise disease, antibiotic resistance and vaccine impact","volume":"43","author":"Gladstone","year":"2019","journal-title":"EBioMedicine"},{"issue":"11","key":"10.1016\/j.vaccine.2021.08.061_b0085","doi-asserted-by":"crossref","first-page":"2640","DOI":"10.1093\/jac\/dks261","article-title":"Identification of acquired antimicrobial resistance genes","volume":"67","author":"Zankari","year":"2012","journal-title":"J Antimicrob Chemother"},{"issue":"1","key":"10.1016\/j.vaccine.2021.08.061_b0090","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1186\/1471-2105-10-421","article-title":"BLAST+: architecture and applications","volume":"10","author":"Camacho","year":"2009","journal-title":"BMC Bioinf"},{"key":"10.1016\/j.vaccine.2021.08.061_b0095","doi-asserted-by":"crossref","first-page":"e167","DOI":"10.7717\/peerj.167","article-title":"Galaxy tools and workflows for sequence analysis with applications in molecular plant pathology","volume":"1","author":"Cock","year":"2013","journal-title":"PeerJ"},{"issue":"2","key":"10.1016\/j.vaccine.2021.08.061_b0100","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1101\/gr.241455.118","article-title":"Fast and flexible bacterial genomic epidemiology with PopPUNK","volume":"29","author":"Lees","year":"2019","journal-title":"Genome Res"},{"key":"10.1016\/j.vaccine.2021.08.061_b0105","doi-asserted-by":"crossref","first-page":"2498","DOI":"10.1101\/gr.1239303","article-title":"Cytoscape: a software environment for integrated models of biomolecular interaction networks","volume":"13","author":"Shannon","year":"2003","journal-title":"Genome Res"},{"issue":"2","key":"10.1016\/j.vaccine.2021.08.061_b0110","doi-asserted-by":"crossref","first-page":"115447","DOI":"10.1016\/j.diagmicrobio.2021.115447","article-title":"Invasive pneumococcal disease caused by serotypes 22F and 33F in Canada: the SAVE study 2011\u20132018","volume":"101","author":"Golden","year":"2021","journal-title":"Diagn Microbiol Infect Dis"},{"issue":"23","key":"10.1016\/j.vaccine.2021.08.061_b0115","doi-asserted-by":"crossref","first-page":"2527","DOI":"10.1016\/j.vaccine.2016.03.058","article-title":"Invasive Streptococcus pneumoniae in Canada, 2011\u20132014: Characterization of new candidate 15-valent pneumococcal conjugate vaccine serotypes 22F and 33F","volume":"34","author":"Golden","year":"2016","journal-title":"Vaccine"},{"issue":"Suppl 4","key":"10.1016\/j.vaccine.2021.08.061_b0120","doi-asserted-by":"crossref","first-page":"iv39","DOI":"10.1093\/jac\/dkz286","article-title":"Comparison of antimicrobial resistance patterns in Streptococcus pneumoniae from respiratory and blood cultures in Canadian hospitals from 2007-16","volume":"74","author":"Golden","year":"2019","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.vaccine.2021.08.061_b0125","unstructured":"Public Health Agency of Canada (PHAC). National laboratory surveillance of invasive streptococcal disease in Canada - annual summary 2018; 2019."},{"issue":"5","key":"10.1016\/j.vaccine.2021.08.061_b0130","doi-asserted-by":"crossref","first-page":"e0178040","DOI":"10.1371\/journal.pone.0178040","article-title":"Phylogenetic analysis of emergent Streptococcus pneumoniae serotype 22F causing invasive pneumococcal disease using whole genome sequencing","volume":"12","author":"Demczuk","year":"2017","journal-title":"PLoS ONE"},{"issue":"1","key":"10.1016\/j.vaccine.2021.08.061_b0135","doi-asserted-by":"crossref","first-page":"60.e9","DOI":"10.1016\/j.cmi.2015.08.027","article-title":"Strain features and distributions in pneumococci from children with invasive disease before and after 13-valent conjugate vaccine implementation in the USA","volume":"22","author":"Metcalf","year":"2016","journal-title":"Clin Microbiol Infect"},{"issue":"8","key":"10.1016\/j.vaccine.2021.08.061_b0140","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1016\/j.jiph.2020.04.012","article-title":"High prevalence of antimicrobial resistance in non-vaccine serotypes of non-invasive\/colonization isolates of Streptococcus pneumoniae: a cross-sectional study eight years after the licensure of conjugate vaccine in Japan","volume":"13","author":"Kawaguchiya","year":"2020","journal-title":"J Infect Public Health"},{"issue":"4","key":"10.1016\/j.vaccine.2021.08.061_b0145","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/j.jinf.2020.07.035","article-title":"Streptococcus pneumoniae serotype distribution and antimicrobial nonsusceptibility trends among adults with pneumonia in the United States, 2009\u20132017","volume":"81","author":"Suaya","year":"2020","journal-title":"J Infect"},{"issue":"7","key":"10.1016\/j.vaccine.2021.08.061_b0150","doi-asserted-by":"crossref","first-page":"2565","DOI":"10.1128\/JCM.39.7.2565-2571.2001","article-title":"Nomenclature of major antimicrobial-resistant clones of Streptococcus pneumoniae defined by the pneumococcal molecular epidemiology network","volume":"39","author":"McGee","year":"2001","journal-title":"J Clin Microbiol"},{"issue":"7","key":"10.1016\/j.vaccine.2021.08.061_b0155","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/S1473-3099(19)30297-X","article-title":"Pneumococcal lineages associated with serotype replacement and antibiotic resistance in childhood invasive pneumococcal disease in the post-PCV13 era: an international whole-genome sequencing study","volume":"19","author":"Lo","year":"2019","journal-title":"Lancet Infect Dis"},{"issue":"34","key":"10.1016\/j.vaccine.2021.08.061_b0160","doi-asserted-by":"crossref","first-page":"5454","DOI":"10.1016\/j.vaccine.2020.06.040","article-title":"Antimicrobial susceptibility and clonality of Streptococcus pneumoniae isolates recovered from invasive disease cases during a period with changes in pneumococcal childhood vaccination, Norway, 2004\u20132016","volume":"38","author":"Siira","year":"2020","journal-title":"Vaccine"},{"issue":"23","key":"10.1016\/j.vaccine.2021.08.061_b0165","doi-asserted-by":"crossref","first-page":"3207","DOI":"10.1016\/j.vaccine.2021.02.063","article-title":"Dynamics of antimicrobial resistance of Streptococcus pneumoniae following PCV10 introduction in Brazil: nationwide surveillance from 2007 to 2019","volume":"39","author":"Brandileone","year":"2021","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2021.08.061_b0170","doi-asserted-by":"crossref","first-page":"687","DOI":"10.3390\/genes10090687","article-title":"The genomics of Streptococcus pneumoniae carriage isolates from UK children and their household contacts, Pre-PCV7 to Post-PCV13","volume":"10","author":"Sheppard","year":"2019","journal-title":"Genes (Basel)"},{"issue":"11","key":"10.1016\/j.vaccine.2021.08.061_b0175","doi-asserted-by":"crossref","first-page":"e1007438","DOI":"10.1371\/journal.ppat.1007438","article-title":"Global emergence and population dynamics of divergent serotype 3 CC180 pneumococci","volume":"14","author":"Azarian","year":"2018","journal-title":"PLoS Pathog"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X21011099?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X21011099?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T11:03:18Z","timestamp":1759402998000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X21011099"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9]]},"references-count":35,"journal-issue":{"issue":"39","published-print":{"date-parts":[[2021,9]]}},"alternative-id":["S0264410X21011099"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2021.08.061","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2021,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Whole genome characterization of Streptococcus pneumoniae from respiratory and blood cultures collected from Canadian hospitals before and after PCV-13 implementation in Canada: Focus on serotypes 22F and 33F from CANWARD 2007\u20132018","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2021.08.061","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}